BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 27
• 28
• 29
• 30

• Business

  Peregrine To Report Financial Results For Second Quarter Of Fiscal Year 2017 After Market Close On December 12, 2016

  December 6, 2016

   · 

  1 min read
• BioMidwest

  Kraig Biocraft Laboratories, Inc. Spider Silk Technology Featured In Episode Of “Xploration Station: Nature Knows Best”

  December 6, 2016

   · 

  2 min read
• BioCapital

  PetLife Pharma’ CEO Dr. Salvagno Provides White Paper On “Venenotherapy” While Preparing For FDA Submission

  December 6, 2016

   · 

  2 min read
• Drug Development

  Global Blood Therapeutics Announces New Details On Its Novel Patient Reported Outcomes (PRO) Tool To Be Used In Phase III HOPE Study

  December 6, 2016

   · 

  9 min read
• Drug Development

  Novartis AG Announces Zykadia First-Line Study Results Showing 16.6 Month Progression-Free Survival In Patients With ALK+ Advanced NSCLC

  December 6, 2016

   · 

  14 min read
• BioMidwest

  Zimmer Biomet Announces The Early Tender Results And Upsizing Of Its Cash Tender Offers For Certain Outstanding Debt Securities

  December 6, 2016

   · 

  7 min read
• Biotech Bay

  Finesse Solutions Launches Second Generation G3Lite+ SmartController For Single-Use Bioreactor Systems

  December 6, 2016

   · 

  2 min read
• Drug Development

  Janssen R&D Release: Daratumumab (DARZALEX) Combination Therapy Showed Consistent Clinical Benefit For Previously-Treated Patients With Multiple Myeloma

  December 6, 2016

   · 

  19 min read
• FDA

  Voluntis Wins FDA Clearance and CE Mark for Diabetes Management App, Insulia

  December 6, 2016

   · 

  4 min read
• Drug Development

  Oncolytics Biotech Inc. Collaborators Present Initial Results From REO 019 Study In Multiple Myeloma Combining REOLYSIN, Bortezomib And Dexamethasone At The American Society of Hematology Annual Meeting

  December 6, 2016

   · 

  5 min read